dimethoxyphenylethylamine has been researched along with 2-(4-chloro-2,5-dimethoxyphenyl)-n-((2-methoxyphenyl)methyl)ethanamine in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (85.71) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Hegarty, CB; Janis, GC; Kealey, SE; Stellpflug, SJ | 1 |
| Alford, KN; Peace, MR; Poklis, A; Poklis, JL; Raso, SA | 1 |
| Andersson, M; Carlier, J; Diao, X; Eriksson, C; Huestis, MA; Josefsson, M; Konradsson, P; Kronstrand, R; Kugelberg, FC; Roman, M; Wohlfarth, A; Wu, X | 1 |
| Dolan, SB; Forster, MJ; Gatch, MB | 1 |
| Nisbet, LA; Scott, KS; Venson, R; Wylie, FM | 1 |
| Galettis, P; Martin, J; Williams, M | 1 |
| Holtkamp, M; Karst, U; Lützen, E; Pütz, M; Schmid, R; Sperling, M; Stamme, I | 1 |
7 other study(ies) available for dimethoxyphenylethylamine and 2-(4-chloro-2,5-dimethoxyphenyl)-n-((2-methoxyphenyl)methyl)ethanamine
| Article | Year |
|---|---|
2-(4-Iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25I-NBOMe): clinical case with unique confirmatory testing.
Topics: Adolescent; Benzylamines; Biomarkers; Biotransformation; Designer Drugs; Dimethoxyphenylethylamine; Epilepsy, Tonic-Clonic; Female; Hallucinogens; Humans; Minnesota; Neurotoxicity Syndromes; Phenethylamines; Substance Abuse Detection; Treatment Outcome | 2014 |
Analysis of 25I-NBOMe, 25B-NBOMe, 25C-NBOMe and Other Dimethoxyphenyl-N-[(2-Methoxyphenyl) Methyl]Ethanamine Derivatives on Blotter Paper.
Topics: Anisoles; Benzylamines; Chromatography, High Pressure Liquid; Dimethoxyphenylethylamine; Phenethylamines; Tandem Mass Spectrometry | 2015 |
25C-NBOMe and 25I-NBOMe metabolite studies in human hepatocytes, in vivo mouse and human urine with high-resolution mass spectrometry.
Topics: Animals; Benzylamines; Chromatography, High Pressure Liquid; Dimethoxyphenylethylamine; Hallucinogens; Hepatocytes; Humans; Male; Mice; Mice, Inbred C57BL; Phenethylamines; Substance Abuse Detection; Tandem Mass Spectrometry | 2017 |
Locomotor and discriminative stimulus effects of four novel hallucinogens in rodents.
Topics: Animals; Anisoles; Benzylamines; Dimethoxyphenylethylamine; DOM 2,5-Dimethoxy-4-Methylamphetamine; Hallucinogens; Locomotion; Male; Mice; N-Methyl-3,4-methylenedioxyamphetamine; Phenethylamines; Rats; Rats, Sprague-Dawley | 2017 |
Application of a Urine and Hair Validated LC-MS-MS Method to Determine the Effect of Hair Color on the Incorporation of 25B-NBOMe, 25C-NBOMe and 25I-NBOMe into Hair in the Rat.
Topics: Animals; Anisoles; Benzylamines; Chromatography, Liquid; Dimethoxyphenylethylamine; Hair; Hair Color; Phenethylamines; Rats; Substance Abuse Detection; Tandem Mass Spectrometry | 2017 |
A Validated Method for the Detection of 32 Bath Salts in Oral Fluid.
Topics: Alkaloids; Anisoles; Australia; Benzylamines; Dimethoxyphenylethylamine; Humans; Illicit Drugs; Methamphetamine; Pentanones; Phenethylamines; Propiophenones; Psychotropic Drugs; Pyrrolidines; Saliva; Substance Abuse Detection | 2017 |
Multimodal imaging of hallucinogens 25C- and 25I-NBOMe on blotter papers.
Topics: Benzylamines; Chromatography, High Pressure Liquid; Dimethoxyphenylethylamine; Hallucinogens; Lysergic Acid Diethylamide; Paper; Phenethylamines; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2020 |